• Congo's Ebola outbreak death toll exceeds 3,000 with over 6,100 confirmed cases.
• The outbreak is the largest and deadliest in Congo's history, surpassing previous epidemics.
• Weak healthcare systems and community resistance hinder efforts to control the spread.
• No approved vaccine or treatment exists for the Bundibugyo strain causing the outbreak.
• The international community has begun supporting containment efforts with financial aid.

The Democratic Republic of Congo is grappling with one of its most significant health crises as the Ebola outbreak's death toll has surpassed 3,000, with over 6,186 cases confirmed. This outbreak, linked to the rare Bundibugyo strain, has become the deadliest in Congo's history, previously surpassed only by the extensive West African epidemic of 2014-2016, which killed over 11,000 people. The outbreak was officially declared on May 15 in Ituri province and has since spread to six provinces, resulting in immense public health challenges due to weak surveillance and community resistance to health directives, as emphasized by health experts and authorities

The current response to the outbreak is hampered by multiple factors, including ongoing conflict in eastern Congo, attacks against health workers, and limited access to adequate healthcare facilities. About 60% of Ebola-related deaths occur outside treatment centers, highlighting the struggle to identify and treat patients promptly. Communities exhibit distrust towards health workers, adding to the obstacles faced in containing the outbreak. The World Health Organization has warned that the epidemic is poised to exceed the past records of deaths and infections, making it essential for health authorities to bolster their response efforts.

As measures to control the outbreak face continuous setbacks, the Congolese government has initiated vaccinations for frontline health workers using the Merck Ervebo vaccine, which is primarily approved for the Zaire strain. Although it is not specifically targeted at Bundibugyo, health officials believe it may provide some level of cross-protection. Furthermore, international support has been mobilized, with the British government recently pledging over £50 million (approximately $67.56 million) to enhance outbreak containment efforts, encompassing surveillance, frontline healthcare, and community outreach initiatives.